Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3

Condition:   Achromatopsia Intervention:   Biological: AAV - CNGB3 Sponsors:   MeiraGTx UK II Ltd;   Syne Qua Non Limited;   Emas Pharma Ltd. Recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials